Effect of Intralipid Infusion in Patients With Recurrent Implantation Failure
Status:
Unknown status
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
The aim of present study is to evaluate the effect of intralipid 20% infusion, once between
days 4 and 9 of the ovarian stimulation, and again within 7 days of a positive pregnancy test
on clinical pregnancy rates in women with unexplained recurrent implantation failure.